| scholarly article | Q13442814 |
| P50 | author | Donovan A Argueta | Q45995585 |
| P2093 | author name string | Valentina Medici | |
| Andrew A Bremer | |||
| Nancy L Keim | |||
| Peter J Havel | |||
| Nicholas V DiPatrizio | |||
| Kimber L Stanhope | |||
| Vivien Lee | |||
| Marinelle V Nunez | |||
| Guoxia X Chen | |||
| Candice Allister Price | |||
| P2860 | cites work | Docosahexaenoyl ethanolamide improves glucose uptake and alters endocannabinoid system gene expression in proliferating and differentiating C2C12 myoblasts | Q38547006 |
| Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages | Q39000393 | ||
| Endocannabinoid modulation of homeostatic and non-homeostatic feeding circuits. | Q39349258 | ||
| Development of a urinary riboflavin adherence marker for a wheat bran fiber community intervention trial. | Q42549155 | ||
| Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties. | Q42824955 | ||
| Fructose affects enzymes involved in the synthesis and degradation of hypothalamic endocannabinoids | Q43189789 | ||
| Sweeteners and Risk of Obesity and Type 2 Diabetes: The Role of Sugar-Sweetened Beverages | Q43886987 | ||
| Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity. | Q45995526 | ||
| Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats. | Q46390700 | ||
| Effects of sucrose, glucose and fructose on peripheral and central appetite signals | Q46483283 | ||
| Sugar Content of Popular Sweetened Beverages Based on Objective Laboratory Analysis: Focus on Fructose Content | Q46957325 | ||
| Fructose intake is a predictor of LDL particle size in overweight schoolchildren | Q47267065 | ||
| Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors | Q48664473 | ||
| Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity | Q60690490 | ||
| Non-endocannabinoid N-acylethanolamines and 2-monoacylglycerols in the intestine | Q87859320 | ||
| Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity | Q24523292 | ||
| Intake of sugar-sweetened beverages and weight gain: a systematic review | Q24630456 | ||
| Activation of the peripheral endocannabinoid system in human obesity | Q24655297 | ||
| A fatty gut feeling | Q26999343 | ||
| Sugar consumption, metabolic disease and obesity: The state of the controversy | Q27968233 | ||
| MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future. | Q30399231 | ||
| Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients | Q33846570 | ||
| Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels | Q33976764 | ||
| Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. | Q34260855 | ||
| A new predictive equation for resting energy expenditure in healthy individuals | Q34305464 | ||
| Endocannabinoids measurement in human saliva as potential biomarker of obesity. | Q34364857 | ||
| Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites. | Q34471868 | ||
| A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults | Q34473275 | ||
| Endocannabinoid signal in the gut controls dietary fat intake. | Q35149416 | ||
| The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis | Q35169067 | ||
| Intestinal lipid-derived signals that sense dietary fat. | Q35183977 | ||
| Riboflavin as an oral tracer for monitoring compliance in clinical research | Q35223271 | ||
| Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat. | Q35680888 | ||
| Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues | Q36353394 | ||
| Perspective: A Historical and Scientific Perspective of Sugar and Its Relation with Obesity and Diabetes | Q36372585 | ||
| Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats | Q36860344 | ||
| Fatty Acid modulation of the endocannabinoid system and the effect on food intake and metabolism. | Q36916109 | ||
| Inhibiting parabrachial fatty acid amide hydrolase activity selectively increases the intake of palatable food via cannabinoid CB1 receptors | Q36977181 | ||
| Endocannabinoids, adipose tissue and lipid metabolism | Q37143606 | ||
| Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans | Q37170824 | ||
| Activating parabrachial cannabinoid CB1 receptors selectively stimulates feeding of palatable foods in rats | Q37301835 | ||
| Oleoylethanolamide exerts anti-inflammatory effects on LPS-induced THP-1 cells by enhancing PPARα signaling and inhibiting the NF-κB and ERK1/2/AP-1/STAT3 pathways | Q37323879 | ||
| N-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP/PKA-dependent signaling. | Q37394743 | ||
| Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice | Q37648708 | ||
| P433 | issue | 2 | |
| P304 | page(s) | E141-E149 | |
| P577 | publication date | 2018-04-10 | |
| P1433 | published in | American Journal of Physiology - Endocrinology and Metabolism | Q15765671 |
| P1476 | title | Plasma fatty acid ethanolamides are associated with postprandial triglycerides, ApoCIII, and ApoE in humans consuming a high-fructose corn syrup-sweetened beverage | |
| P478 | volume | 315 |
| Q90472248 | Serum Endocannabinoid Levels in Patients With End-Stage Renal Disease | cites work | P2860 |
Search more.